Shinya Goto: DOACs Across Populations Through Patient-Level Evidence
Shinya Goto, Director and Chairman in Metabolic Disease Research Center, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in European Heart Journal, adding:
“Asian vs non Asian: huge patient level-meta analysis of DOAC developmentat trials!”
Title: Direct oral anticoagulants vs warfarin in Asian vs non-Asian patients with atrial fibrillation: a patient-level meta-analysis from COMBINE AF
Authors: Tze-Fan Chao, Eugene Braunwald, Michael G. Palazzolo, Elliott M. Antman, Anthony P. Carnicelli, John W. Eikelboom, Christopher B. Granger, Shinya Goto, Eri Toda Kato, Gregory Y. H. Lip, Manesh R. Patel, Christian T. Ruff, Lars Wallentin, Robert P. Giugliano
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 30, 2026, 14:53Pall T. Onundarson: Anticoagulation Guidelines Under the Influence of Pharmaceuticalisation
-
Oct 30, 2026, 14:27Isabella Presch: From Innovation to Accessibility in Cell and Gene Therapy
-
Oct 30, 2026, 14:00Abdul Mannan: A Negative PCR Does Not Exclude β-Thalassaemia
-
Oct 30, 2026, 13:53Matteo Foschi: Can Thrombolysis Safely Treat Stroke After Cardiac Procedures?
-
Oct 30, 2026, 13:42Wolfgang Miesbach: Gene Therapy-Associated Leukaemia With Clonal Persistence Over 16 Years
-
Oct 30, 2026, 12:47Louise St. Germain Bannon: Turning Thrombosis Awareness into Stroke Prevention
-
Oct 30, 2026, 12:36Aryabhatta Sadhu: Sickle Cell Crisis Recognising When Treatment Must Change
-
Oct 30, 2026, 12:22Fabrice Cognasse: The Future of Blood Banks From Transfusion Support to Precision Medicine
-
Oct 30, 2026, 12:09Carmelo Gurnari: Clonal Dynamics in the Bone Marrow During Sepsis and Emergency Haematopoiesis